trial

Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders

NCTId NCT02930005
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 8 (actual)
Sponsored by The University of Texas Health Science Center, Houston
Primary completion 2016-10-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
8 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2015-08-07
Primary completion
2016-10-06
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Meclofenamic acidPentosan polysulfate sodium

Sponsors

The University of Texas Health Science Center, HoustonLead Sponsor

Sites

1 total
Houston, United States

Linked catalysts

1
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With — primary completion2016-10-06

Facts & assertions

4 sourced
Enrollment
8
Phase
PHASE2
Primary Completion Date
2016-10-06
Status
COMPLETED
relationships
The graph out of here
drug
Meclofenamic acid
drug
Pentosan polysulfate sodium
drug
lead_sponsor
The University of Texas Health Science Center, Houston
company
indication
Bipolar Disorder
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication